Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04592887 · ClinicalTrials.gov registry record · NA
Feasibility Study of FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases
A NA study, sponsored by Varian, a Siemens Healthineers Company.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT04592887 is a NA study that has completed, run by Varian, a Siemens Healthineers Company. The registered enrollment target is 10 participants.
The verdict
NCT04592887, a NA study, has completed, sponsored by Varian, a Siemens Healthineers Company.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
This purpose of this study is to assess the feasibility of FLASH radiotherapy for the palliative treatment of painful bone metastases. FLASH radiotherapy is radiation treatment delivered at ultra-high dose rates compared to conventional radiation treatment.
Interventions
- RADIATION FLASH Radiotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2020-11-03 |
| Est. Completion | 2023-03-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04592887
The ClinicalTrials.gov registry entry for NCT04592887 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Varian, a Siemens Healthineers Company, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FLASH Radiotherapy is the first listed.
NCT04592887 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04592887 about?
NCT04592887 is a clinical study titled "Feasibility Study of FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases". This purpose of this study is to assess the feasibility of FLASH radiotherapy for the palliative treatment of painful bone metastases. FLASH radiotherapy is radiation treatment delivered at ultra-high dose rates compared to conventional radiation treatment.
What is the current status of trial NCT04592887?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2020-11-03. Estimated completion is 2023-03-27.
What interventions are being tested in trial NCT04592887?
The interventions under investigation include: FLASH Radiotherapy (RADIATION).
Who is sponsoring clinical trial NCT04592887?
This trial is sponsored by Varian, a Siemens Healthineers Company, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.